Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SCO-spondin, encoded by the SSPO gene, is a giant multidomain extracellular matrix glycoprotein secreted by the subcommissural organ in the brain during development, involved in axonal growth, Reissner’s fiber formation, and neuroepithelial differentiation[1][2][3][4][5]. However, SSPOP ("SCO-spondin, pseudogene") refers to a pseudogene related to SSPO, not a protein-coding gene with functional protein product[3][5][7]. Most sources refer to SSPOP as a pseudogene, which means it is not a direct molecular or therapeutic target and does not encode a functional protein product[3][5][7]. Functional and therapeutic information applies to the protein-coding SSPO gene, not to SSPOP. Key Points: - SSPOP is a pseudogene, a non-protein-coding genetic segment, so it is not considered a molecular target for drugs or known to have direct roles in disease, mechanism, drug interaction, or biomarker status[3][5][7]. - Information about biological function, disease implication, and potential as a therapeutic target would refer to SSPO (SCO-spondin), not to SSPOP (the pseudogene). Summary of Deviation/Correction: - The majority of functional information found is for SSPO, which encodes the SCO-spondin protein involved in neural development. SSPOP is a related pseudogene and does not produce protein or act as a therapeutic target[3][5][7]. - Therefore, "is_incorrect" is true for interpreting SSPOP as a molecular target in the therapeutic sense. For research about the actual protein, refer to "SCO-spondin" or the SSPO gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SCO-spondin pseudogene (SSPOP).